Hogan Lovells Our thinking banner

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Insights and Analysis

EDPB Guidelines on processing personal data for scientific research – Key takeaways

28 May 2026

Insights and Analysis

FDA one-day inspections pilot: What to expect and how to prepare

27 May 2026

News

Pillars of exclusivity: Regulatory data protection regime for pharma in China

26 May 2026

News

French Legal and Regulatory Update – April 2026

26 May 2026

News

Drug repurposing: FDA seeks comments on how to address unmet medical needs

26 May 2026

News

House committee report signals limits on foreign clinical data

06 May 2026

Insights and Analysis

Supreme Court hears ‘skinny labeling’ drug patent infringement case

01 May 2026

News

Federal marijuana rescheduling arrives

01 May 2026

Insights and Analysis

China’s medical insurance enforcement in 2026: New rules, active campaign, and implications for pharmaceutical companies

24 April 2026

News

Polling, history point to Democratic takeover of House and possibly Senate – clients should prepare now

22 April 2026

Insights and Analysis

China tightens criminal enforcement of bribery: What it means for health care companies

17 April 2026

News

Balancing transparency and access: Controversy over confidential medicinal product pricing in Spain

25 March 2026

Load more

Digital Client Solutions

Empowering you to lead change through our digital solutions.